COVID-19: Nigeria To Receive 29.8 Million Doses Of Johnson & Johnson

On Apr 27, 2021

The Nigerian government is expecting about 29.8 million doses of the Johnson & Johnson (J&J) COVID-19 vaccine.

The Executive Director of the National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib disclosed this at the weekly media briefing of the COVID-19 Presidential Steering Committee in Abuja.

“Federal government signed off to receive the vaccines through the African Union (AU), while vaccine deliveries through the COVAX facility were expected by the end of May or early June.

“Nigeria would have completed the process of administering the second dose of the AstraZeneca vaccine to those who got the first dose by then,” Shuaib said.

This was to mitigate the negative concerns about the delayed deliveries of AstraZeneca vaccines, thereby ensuring the sustained supply of vaccines for the smooth continuation of the exercise.

He noted that as of April 26, a total of 1,173, 869 Nigerians, representing 58.3 per cent of the eligible persons targeted in the first phase have received their first dose of the AstraZeneca vaccine.

The government anticipates a delay in vaccine supply to Nigeria which may also affect and impact the remaining phases of the vaccination exercise.

Kamila/premium